J. B. Chemicals & Pharmaceuticals バランスシートの健全性
財務の健全性 基準チェック /66
J. B. Chemicals & Pharmaceuticalsの総株主資本は₹32.1B 、総負債は₹816.4Mで、負債比率は2.5%となります。総資産と総負債はそれぞれ₹40.3Bと₹8.2Bです。 J. B. Chemicals & Pharmaceuticalsの EBIT は₹8.1Bで、利息カバレッジ比率33.1です。現金および短期投資は₹4.2Bです。
主要情報
2.5%
負債資本比率
₹816.40m
負債
| インタレスト・カバレッジ・レシオ | 33.1x |
| 現金 | ₹4.17b |
| エクイティ | ₹32.12b |
| 負債合計 | ₹8.17b |
| 総資産 | ₹40.29b |
財務の健全性に関する最新情報
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 27
These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well
Jun 28We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29Recent updates
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 27J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
Nov 09J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Business Is Yet to Catch Up With Its Share Price
Sep 24Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation
Aug 15J. B. Chemicals & Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 11These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well
Jun 28J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Apr 19J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 09J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Dec 22We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25
Aug 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50
Feb 11Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Sep 21J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Jun 15Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50
Feb 16財務状況分析
短期負債: JBCHEPHARMの 短期資産 ( ₹19.1B ) が 短期負債 ( ₹6.2B ) を超えています。
長期負債: JBCHEPHARMの短期資産 ( ₹19.1B ) が 長期負債 ( ₹2.0B ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: JBCHEPHARM総負債よりも多くの現金を保有しています。
負債の削減: JBCHEPHARMの負債対資本比率は、過去 5 年間で3%から2.5%に減少しました。
債務返済能力: JBCHEPHARMの負債は 営業キャッシュフロー によって 十分にカバー されています ( 912.6% )。
インタレストカバレッジ: JBCHEPHARMの負債に対する 利息支払い は EBIT ( 33.1 x coverage) によって 十分にカバーされています。